← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2017Last known activity
Nov 19, 2020
Defunct as of Dec 31, 2025
Timeline
2000s
- Jun 1, 2008
Sentien Biotechnologies, Inc.— Founded
2020s
- Dec 31, 2025
Sentien Biotechnologies, Inc.— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT04445220Lead sponsorPhase 1/Phase 2Nov 19, 2020
- NCT03015623Study chairPhase 1/Phase 2May 1, 2017
- NCT03015623Lead sponsorPhase 1/Phase 2May 1, 2017
Details
- Founded
- Lexington, MA, US Jun 1, 2008
- Last known activity
- Nov 19, 2020